in a study to compare the prophylactic efficacy of passive and passive-active immunization against hepatitis b virus ( hbv ) among newborn infants of hbv carrier mothers positive for hepatitis b e in korea , both regimens resulted in effective protection against development of hepatitis b surface antigen ( hbsag ) : 10 of 12 recipients of hepatitis b immune globulin ( hbig ) and 25 of 29 recipients of hbig and vaccine during nine months of follow-up .
C0019163
hepatitis b
C0062525
hbig